Presence and Interactions of Entamoeba histolytica Lectin and p53 Protein in Colorectal Cancer
,
Abstract
Background: We aimed to analyze the presence of Entamoeba histolytica lectin light chain antigen and p53 protein in colorectal cancer biopsies to uncover potential antigenic interactions between them.
Methods: Overall, 150 colorectal cancer biopsy samples were subjected to examination for the specific E. histolytica antigen and p53 protein through the application of the immunohistochemical technique. To augment diagnostic precision, the western blotting method was employed and its results were compared with those obtained from immunohistochemistry (IHC).
Results: Among the 150 colorectal cancer biopsy samples examined, 100 cases tested positive for the p53 protein, while 19 cases exhibited positivity for the E. histolytica light chain lectin antigen. Notably, only 14 cases demonstrated a positive presence for both the p53 protein and the E. histolytica protozoan.
Conclusion: Entamoeba histolytica, a leading cause of parasitic infections, raises questions about its potential link to colorectal cancer, specifically in connection with the p53 protein. The findings presented in this investigation signal the need for further research to comprehensively understand the implications of E. histolytica in colorectal cancer diagnosis and treatment strategies.
2. Aguirre García M, Gutiérrez-Kobeh L, López Vancell R. Entamoeba histolytica: adhesins and lectins in the trophozoite surface. Molecules. 2015; 20(2):2802-15.
3. Petri WA, Jr., Haque R, Mann BJ. The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu Rev Microbiol. 2002;56:39-64.
4. Ventura-Juárez J, Campos-Rodríguez R, Jarillo-Luna RA, et al. Trophozoites of Entamoeba histolytica express a CD59-like molecule in human colon. Parasitol Res.. 2009;104(4):821-6.
5. Rico G, Leandro E, Rojas S, Giménez JA, Kretschmer RR. The monocyte locomotion inhibitory factor produced by Entamoeba histolytica inhibits induced nitric oxide production in human leukocytes. Parasitol Res. 2003;90(4):264-7.
6. Betanzos A, Schnoor M, Javier-Reyna R, et al. Analysis of the epithelial damage produced by Entamoeba histolytica infection. J Vis Exp. 2014 Jun 12;(88):51668.
7. Dominic C, Kelly S, Melzer M. Refractory inflammatory bowel disease – Entamoeba histolytica, the forgotten suspect. Clinical Infection in Practice. 2023;20:100245.
8. Michel M, Kaps L, Maderer A, Galle PR, Moehler M. The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy. Cancers (Basel). 2021 May 11;13(10):2296.
9. Lee YA, Min A, Shin MH. O-deGlcNAcylation is required for Entamoeba histolytica-induced HepG2 cell death. Microb Pathog. 2018;123:285-95.
10. Vosseller K, Sakabe K, Wells L, Hart GW. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification. Curr Opin Chem Biol. 2002;6(6):851-7.
11. de Queiroz RM, Madan R, Chien J, Dias WB, Slawson C. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells. J Biol Chem. 2016;291(36):18897-914.
12. Mendoza L, Orozco E, Rodríguez MA, et al. Ehp53, an Entamoeba histolytica protein, ancestor of the mammalian tumour suppressor p53. Microbiology (Reading). 2003;149(4):885-93.
13. Miller RT. Avoiding pitfalls in diagnostic immunohistochemistry-important technical aspects that every pathologist should know. Semin Diagn Pathol. 2019 Sep;36(5):312-335.
14. Hirano S. Western blot analysis. Methods Mol Biol. 2012;926:87-97.
15. Ali IK, Solaymani-Mohammadi S, et al. Tissue invasion by Entamoeba histolytica: evidence of genetic selection and/or DNA reorganization events in organ tropism. PLoS Negl Trop Dis. 2008;2(4):e219.
16. Betanzos A, Bañuelos C, Orozco E. Host Invasion by Pathogenic Amoebae: Epithelial Disruption by Parasite Proteins. Genes (Basel). 2019;10(8).
17. Hemadi A, Ekrami A, Oormazdi H, et al. Bioconjugated fluorescent silica nanoparticles for the rapid detection of Entamoeba histolytica. Acta Trop. 2015;145:26-30.
18. Haghighi L, Razmjou E, Rafiei-Sefiddashti R, Meamar AR, Akhlaghi L. Entamoeba histolytica and Probable Effect on Production Microsatellite Instability in Colorectal Cancer. Curr Microbiol. 2022;79(4):111.
19. Simşek H, Elsürer R, Sökmensüer C, Balaban HY, Tatar G. Ameboma mimicking carcinoma of the cecum: case report. Gastrointest Endosc. 2004;59(3):453-4.
20. Åberg E, Saccoccia F, Grabherr M, Ore WYJ, Jemth P, Hultqvist G. Evolution of the p53-MDM2 pathway. BMC Evol Biol. 2017;17(1):177.
21. Gomes AS, Trovão F, Andrade Pinheiro B, et al. The Crystal Structure of the R280K Mutant of Human p53 Explains the Loss of DNA Binding. Int J Mol Sci. 2018;19(4):1184.
22. Bartas M, Brázda V, Červeň J, Pečinka P. Characterization of p53 Family Homologs in Evolutionary Remote Branches of Holozoa. Int J Mol Sci. 2019;21(1):6.
| Files | ||
| Issue | Vol 20 No 2 (2025) | |
| Section | Original Article(s) | |
| Keywords | ||
| Entamoeba histolytica p53 protein Immunohistochemistry (IHC) Western blotting | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
